Adial Pharmaceuticals achieves key milestones for drug AD04, secures FDA approval and new patents.
From GlobeNewswire: 2025-03-04 08:30:00 Adial Pharmaceuticals, Inc. reported successful completion of a key pharmacokinetics study for AD04, confirming bioavailability and